- Home
- ASPI vs EHAB Comparison
ASPI vs EHAB Comparison
Compare ASPI & EHAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASPI
- EHAB
- Stock Information
- Founded
- ASPI 2021
- EHAB 2014
- Country
- ASPI United States
- EHAB United States
- Employees
- ASPI N/A
- EHAB N/A
- Industry
- ASPI Major Chemicals
- EHAB Hospital/Nursing Management
- Sector
- ASPI Industrials
- EHAB Health Care
- Exchange
- ASPI Nasdaq
- EHAB Nasdaq
- Market Cap
- ASPI 470.6M
- EHAB 401.6M
- IPO Year
- ASPI 2022
- EHAB N/A
- Fundamental
- Price
- ASPI $5.80
- EHAB $9.69
- Analyst Decision
- ASPI Strong Buy
- EHAB Hold
- Analyst Count
- ASPI 2
- EHAB 3
- Target Price
- ASPI $4.50
- EHAB $8.50
- AVG Volume (30 Days)
- ASPI 1.9M
- EHAB 294.0K
- Earning Date
- ASPI 05-19-2025
- EHAB 05-07-2025
- Dividend Yield
- ASPI N/A
- EHAB N/A
- EPS Growth
- ASPI N/A
- EHAB N/A
- EPS
- ASPI N/A
- EHAB N/A
- Revenue
- ASPI $4,144,225.00
- EHAB $1,032,300,000.00
- Revenue This Year
- ASPI $690.06
- EHAB $5.33
- Revenue Next Year
- ASPI $93.09
- EHAB $4.86
- P/E Ratio
- ASPI N/A
- EHAB N/A
- Revenue Growth
- ASPI 857.04
- EHAB N/A
- 52 Week Low
- ASPI $1.86
- EHAB $6.85
- 52 Week High
- ASPI $9.33
- EHAB $10.70
- Technical
- Relative Strength Index (RSI)
- ASPI 57.28
- EHAB 75.75
- Support Level
- ASPI $5.16
- EHAB $7.89
- Resistance Level
- ASPI $5.95
- EHAB $8.12
- Average True Range (ATR)
- ASPI 0.42
- EHAB 0.29
- MACD
- ASPI -0.01
- EHAB 0.18
- Stochastic Oscillator
- ASPI 83.87
- EHAB 97.66
About ASPI ASP Isotopes Inc.
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.
About EHAB Enhabit Inc.
Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services to adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing an advanced, life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.